BIO to Ask Congress to Restore SBIR Grant Eligibility for Small Biotech Companies.Senate Committee to Hold Roundtable on SBIR SBIR Small Business Innovation Research (program/grant) SBIR Space Based Infra-Red SBIR Speaker-Boundary Interference SBIR Site Backsurface-referenced Ideal Plane/Range (silicon wafers) Grants Tomorrow WASHINGTON -- At a Congressional roundtable to be held tomorrow, the Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links
n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. companies to enable them to compete for Small Business Innovation Research (SBIR) grants. The roundtable will be held by the Senate Committee on Small Business and Entrepreneurship to prepare for the upcoming reauthorization of the SBIR program, a key federal program designed to support small business innovation. Because of a rule change in 2003, small majority venture-backed biotech companies are ineligible to compete for SBIR grants. BIO has asked Congress to restore eligibility to these small biotech companies so they will able to again compete for SBIR grants. "By excluding these biotech companies from the SBIR program, a less competitive system is preventing the best science and innovation from being funded. Meanwhile, some companies have taken advantage of the system by receiving hundreds of awards," said Alan Eisenberg, BIO Executive Vice President for Emerging Companies and Business Development. "Without SBIR grants, companies have been forced to postpone, sometimes indefinitely, promising new therapies. This is not in the best interest of patients." Eisenberg will be joined at the roundtable by executives from two small biotech companies who also will testify for the need for reform of eligibility standards. Douglas Doerfler, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of MaxCyte, Incorporated, and Dr. Gary McGarrity, Executive Vice President of Scientific and Clinical Affairs at VIRxSYS Corporation, will address how the current eligibility requirements have prohibited further research into promising new therapies for diseases such as cystic fibrosis cystic fibrosis (sĭs`tĭk fībrō`sĭs), inherited disorder of the exocrine glands (see gland), affecting children and young people; median survival is 25 years in females and 30 years in males. . [TABLE OMITTED] About BIO BIO represents more than 1,100 biotechnology companies Top 100 Biotechnology Companies The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies. , academic institutions, state biotechnology centers and related organizations across the United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. and 31 other nations. BIO members are involved in the research and development of healthcare, agricultural, industrial and environmental biotechnology Environmental biotechnology is when biotechnology is applied to and used to study the natural environment. Environmental biotechnology could also imply that one try to harness biological process for commercial uses and exploitation. products. BIO also produces the annual BIO International Convention, the global event for biotechnology. www.bio.org
Upcoming BIO Events
-- Pacific Rim Summit on Industrial Biotechnology and Bioenergy
November 14-16
Honolulu, Hawaii
-- BIO CEO & Investor Conference
February 11-13, 2008
New York, NY
-- BIO International Convention
June 17-20, 2008
San Diego, CA
|
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion